Effect of Interleukin 17 some Physiological Changes in Rats Undergo Bile Duct Ligation and CCl4

 

Rusul Arif, Haider Salih Jaffat

Faculty of Science, University of Kufa

*Corresponding author e-mail: haider_salih1968@yahoo.com

 

ABSTRACT:

This study was conducted at the laboratory of department of biology, faculty of science/university of Kufa during the period extended from 7, September, 2016 to 5, February, 2017, 45 male rats that was used which is divided in to three groups, Group 1: male rats administered with drinking water as negative control (N. C.). Group 2: male rats administered with CCL4 for one month, Group 3: male rats undergo Bile duct ligation for one week,. At the end of treatment period, which has been extended for five weeks, male rats have been sacrificed and blood  samples obtained for assessment of (IL-17 and levels of ALT, AST and ALP also, levels of T.C, T.G., LDL, HDL and  VLDL). The result have a significant elevate (p< 0.05) in level of IL-17  and activities of liver enzymes AST, ALT, ALP, cholesterol, TG, HDL,VLDL and LDL in rats undergo BDL and CCL4 treatment compare to control groups.    .

 

KEYWORDS: Bile duct ligation, Interleukin 17

 

 

 


INTRODUCTION:

The liver is important organ of vertebrates and some other animals1 .In the human it is situated in the upper right of the abdomen, below the diaphragm. The liver has a wide range of functions, including detoxification of various metabolites, protein synthesis, and the production of biochemical’s necessary for digestion2. The liver is a gland and plays a major role in metabolism with many functions in the human body, including regulation of glycogen storage, breakdown of red blood cells, plasma protein synthesis, and hormone production. It is an accessory digestive gland and produces bile, an alkaline compound which aids in digestion via the emulsification of lipids. The gallbladder, a small pear like organ that located just under the liver, stores bile produced by the liver3.

 

The liver highly specialized tissue consisting of mostly hepatocytes regulates a wide variety of biochemical reactions, including the synthesis and breakdown of small and complex molecules, many of which are necessary for normal vital functions2. Liver damage leads to an inflammatory response and to the activation and proliferation of mesenchymal cell populations within the liver which remodel the extracellular matrix as part of an orchestrated wound-healing response. Chronic damage results in a progressive accumulation of scarring proteins (fibrosis) that, with increasing severity, alters tissue structure and function, leading to cirrhosis and liver failure. Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases, including viral hepatitis B or C infection4. The fibroblasts are derived from sources within and out with the liver. Other fibroblasts emerge from the portal tracts within the liver. In addition, fibrogenic fibroblasts may also be generated through liver epithelial (hepatocyte and biliary epithelial cell)–mesenchymal transition. Activated myofibroblasts, predominantly derived from the hepatic stellate cells (HSCs). Transforming growth factor-β and platelet-derived growth factor are classic profibrogenic signals that activate HSC proliferation5. In addition, proinflammatory cytokines and chemokines coordinate macrophages, T cells, natural kill T cell NKcells, and liver sinusoidal endothelial cells in complex fibrogenic and regression processes. In addition, fibrogenesis involve angiogenesis, Hepatic inflammation is the driving force behind liver fibrosis4. Many causes are responsible for liver fibrosis include alcoholic liver disease (ALD), non-alcoholic steatohepatitis (NASH), chronic hepatitis C, primary biliary cirrhosis7. Primary biliary cirrhosis (PBC) is considered an autoimmune disease, with immune damage of the interlobular bile ducts resulting in a regularly progressive ductopenia. PBC is generally a progressive disease leading to cirrhosis and death, although there have been reports of prolonged survival, with minimal progression of disease. Patients who are asymptomatic at appearance have a longer survival than those who are symptomatic. About one third of patients who are asymptomatic at appearance become symptomatic within 5 years. Symptomatic patients have an 8 year survival rate of approximately 50%. Survival models have been developed to predict outcome more precisely and are useful in determining the timing for liver transplantation. Patients with more difficult histological disease at diagnosis, however, have 30% and 50% rates of requiring liver transplantation or death over 10 and 20 years, respectively, despite treatment 6.

 

MATERIALS AND METHODS:

Experimental Animals:

Using 45 adult male rats (Rattus norvegicus) weighting 200-250 gm were obtained from the animals house in high institutes of fertility, University of Nahrain. The animals were housed in the animal house of Faculty of Science, University of Kufa, under standard environment condition (temperature 25-28 C° and 12 hr light-dark cycle) and allowed access to standard laboratory diet and water.

 

Experimental Protocol:

The rats were kept in animal house for acclimation to the laboratory condition for two weeks before they were used for the experiment. each group was formed 15 rats:

Group (1) rats were administrated of normal saline (as negative control).

Group (2) rats administered with CCl4 for one month

Group (3) rats BDL for one week

 

Blood Collection:

At the end of experiments, each animal was  anaesthetized by the mixture of xylazine 0.1 ml and ketamine 0.5 ml and they were scarified 15. Heart cut was finished with a 5 ml expendable syringe and 2-5 ml blood was drawn delicately and gradually. The blood was put in test tube containing gel and left for 30 minutes in room temperature and used to get serum through centrifugation at 3000 rpm for 15 minutes to separate serum and put in Epindroff tubes which kept at (- 20) in a cooler for assurance biochemical examination.

 

Measurement of Interleukin 17(IL17):

This laboratory test was determined by ELISA kit Bioassay Technology Laboratory (Catalog No: E015).

 

Determination of Serum Transaminase Activity:

Colorimetric determination of ALT and AST activity according to the Reitman and Frankel method 8, by using biomerieux kit.

 

Determination of Alkaline Phosphatase Activity:

Colorimetric determination of ALP according to Walters and Gerarde9 by using Linear chemicals kit. 

 

Assessment of Total Cholesterol (TC):

Total cholesterol kit for quantitative determination of total cholesterol in human serum was supplied by Biolabo SA, France10.

 

Assessment of HDL- Cholesterol (HDL-C):

Serum HDL-Cholesterol level was measured by HDL-Cholesterol phosphotungstic acid (PTA) precipitant kit (Biolabo SA, France) 11.

 

Assessment of triglycerides (TG):

Triglycerides Kit was supplied by Biolabo SA, France. for measureable of triglycerides in human serum12.

 

Assessment of very low Density Lipoprotein:

Very Low Density Lipoprotein (VLDL) was measured by the next principle: VLDL = TG (mg/dl) / 5 11.

 

Assessment of low Density Lipoprotein Level:

Low Density Lipoprotein (VLDL) were measured by the next formula:

LDL=TC(mg/dl)-VLDL(mg/dl)-DL(mg/dl).11

 

Statistical Analysis:

The results were expressed as (Mean ± Standard Error) and Correlation coefficients were performed by using megastat.snd all comparison was performed by unpaired sample t-test, while the figures constructed using EXEL program. P-value < 0.05 was used as a level of statistically significant 13.

 

RESULTS:

Effect of CCl4 and Bile Duct Ligation on level of IL17 in rats:

The result in figure (1) when compared male rat’s with control shows significant increase (p<0.05) in serum level of INT17 in both of CCl4 for period one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (1): Changes in Interleukin17 level  in male rat’s treated with CCl4 for one month and BDL for one week.

 

Effect of CCl4 and Bile Duct Ligation on level of liver enzyme in rats.

The result in figure (2-3-4) when compared male rat’s with control shows significant increase in serum level of AST, ALT, ALP in both of CCl4 for period one month  and BDL1 for one week .

 

Values are mean ± SE. *significantly different at p<0.05

Figure (2): Changes in AST level  in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (3): Changes in ALT level  in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (4): Changes in ALP level  in male rat’s treated with CCl4 for one month and BDL for one week.

 

Effect of CCl4 and Bile Duct Ligation on level of Lipid profile in rats.

The result in figure (45-6-7-8-9) when compared male rat’s with control shows significant increase in serum level of LDL,VLDL ,TG  ,cholesterol and HDL in both of CCL4 for period one month  and BDL1 for one week .

 

Values are mean ± SE. *significantly different at p<0.05

Figure (5): Changes in LDL level  in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (6): Changes in VLDL level in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (7): Changes in TG level in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (8): Changes in Cholesterol level in male rat’s treated with CCl4 for one month and BDL for one week.

 

Values are mean ± SE. *significantly different at p<0.05

Figure (9): Changes in HDL level in male rat’s treated with CCl4 for one month and BDL for one week.

 

DISCUSSION:

The results from this study shows a significantly raise in INT17(p<0.05) in this groups gives CCl4  and BDL compared with the control, these increased due to chronic inflammation in multiple organs, including heart, lungs, lymph nodes and liver. Severe cholangitis and hepatitis gave rise to markedly elevated liver enzymes and jaundice this result agree with 14. Interleukin-17 (IL-17) is secreted mainly by activated CD4+ and CD8+ T lymphocytes, while its receptor is distributed ubiquitously. IL-17 has been classified as a proinflammatory cytokine because of its ability to induce the expression of many mediators of inflammation, most strikingly those that are involved in the proliferation, maturation and chemotaxis of neutrophils. Increased levels of IL-17 have been associated with several conditions, including airway inflammation, rheumatoid arthritis, intraperitoneal abscesses and adhesions, inflammatory bowel disease, allograft rejection, psoriasis, cancer and multiple sclerosis. This review provides an overview of IL-17 activities, concentrating on those that lead to neutrophil recruitment15. IL-17 expression in the liver tissues of the patients was positively correlated with inflammation grade and fibrosis stage, and positively stained lymphocytes suggested that IL-17 takes part in chronic HBV infection. The highest IL-17 levels in the serum and liver were observed in Liver Cirrhosis patients, suggesting that IL-17 might contribute to the pathogenesis and or progression of liver fibrosis. Therefore, IL- 17 represents a potential therapeutic target for the prevention of liver tissue damage in HBV-infected patients. Because of the inflammatory reaction of the hepatic tissues in CHB, activated interstitial cells can produce large amounts of TGF-β. TGF-β plays an important role in the differentiation of IL-17. Th17 is a recently described CD4+ helper T cell subset that produces proinflammatory mediators IL-17 and IL-6, which can exacerbate liver damage during chronic HBV infection16. Effect of CCL4 and Bile Duct Ligation on level of liver enzyme in rats. The results from this study demonstrate that hepatotoxicity of CCl4 was clearly observed through a significant raised of  ALP, AST and ALT in CCl4 treated rats in contrast with control, as it has been previously reported that CCl4 is considered as hepatotoxines in the experimental animals study to form damage of liver17. Administration of CCl4 causes deterioration of liver function tests such as AST, ALT and ALP revealed hepatic dysfunction, which be a secondary events following CCl4-induced liver damage, with the consequent leakage from hepatocyte18. The increased level of ALP, AST and ALT this indicate these enzymes out from liver into stream of blood at the indicate of tissue harm, which is associated with liver necrosis25. The data recorded in the present study showed significant enhancement of the ALP activity following BDL in rats. This increase may be attributable to the retention of bile salts that damaged the membrane and consequently leads to the passing of the ALP enzyme into circulation21, 26. It is known that, liver and bile duct disorders are followed by increased activity of ALP which is especially characteristic of the cholestastic syndrome20. Moreover, it has already been proved that in cholestasis the bile salts induce synthesis of new molecules of ALP19. The present study confirmed the finding of22. Who explained elevation in the serum enzymes AST and ALT to the increase in hepatic cell membrane fluidity that led to enzyme release into circulation, in accord with the finding of23. The administration of HaE substantially attenuated the flares of the hepatic enzymes as evident by 77.86, 70.15 and 47.72% improvement in the activities of serum ASAT, ALAT and ALP respectively, in the BDL treated rats indicating maintenance of functional integrity of hepatic cell membrane23. Effect of CCl4 and Bile Duct Ligation on level of Lipid profile in rats. The results from this study show a significantly raise in (LDL, VLDL, HDL, Cholesterol and TG), the group treated by CCl4 and BDL  and compared with the control, these increased due to oxidative stress cause by CCl4 and accumulation of bile this result agree with 24 ,18 .

 

REFERENCES:

1.     Misih, A., Sherif, R.Z., Bloomston, M. (2010). Liver Anatomy. Surgical Clinics of North America, 643–53.

2.     Eric, S. and Allen. (2002). Human Anatomy and Physiology. 7th. ed.  Northeastern University, BIO., 4161-

3.     Gerard, J., Tortora., Bryan, H., and Derrickson.( 2008). Principles of Anatomy and Physiology.12th ed, p. 945.

4.     Su, T-H, Kao, J-H and Liu, C-J. (2014). Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis. Int. J. Mol. Sci., 15, 10578-10604.

5.     Baiocchini, A., Montaldo, C., Alice Conigliaro, A., and et al. (2016). Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.

6.     Corpechot, C., Carrat, F., and Bahr, A. (2005). The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology, 128:297–303.

7.     Friedman, S.L. (2008). Mechanisms of hepatic fibro genesis. Gastroenterology, 1655–1669

8.     Reitman, S. and Frankel, S. (1957). A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic.

9.     Walter, M and Gerarde, H. (1970) Ultra micro method for the determination of conjugated and total bilirubin in serum or plasma. Microchemistry Journal, 15:231-36.

10.   Richmond, W. (1973). Preparation and Properties of Cholesterol Oxidase from Nocardia species and its Applications to the Enzymatic Assay of Total Cholesterol in Serum. Clin. Chem., 19:1350-1356.

11.   Tietz, N.W. (1999). Text book of Clinical Chemistry, 3rd Ed., C.A.  Burtis, E.R. Ashwood, W.B. Saunders. 703-1699.

12.   Fossati, P. and Prencipe, L. L. (1982). Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem., 28: 2077-2080.

13.   Al-Rawi, K. (2000). Entrance to the Statistics. Second edition. Faculty of Agriculture and Forestry, University of Mosul.

14.   Frank, T.(2014). Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clinical and Experimental Gastroenterology, 7 297–306.

15.   Ichikawa, M., Takahashi, N., Yada, Y., Koike, Y. and et al. (2010). Selectively High Levels of Serum Interleukin 17 in a Newborn Infant with Progressive Severe Cholestasis. www.pediatrics.org/cgi/doi/10.1542/peds.2009-3053

16.   Wen J., Jun, H. and Zhao, Q.(2012). Expression of Interleukin17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL17 in HBV infection. https://diagnosticpathology.biomedcentral.com/articles/10.1186/17461596840

17.   Johnston, DE. and Kroening, C. (1998). Mechanism of early carbon tetrachloride toxicity in cultured rat hepatocytes. Pharmacol. Toxicol., 83-231.

18.   Zainab, S. (2013). Study of the Protective Effects of Ginger Extracts Against hepatic Induced by Carbon Tetrachloride in Rats. A thesis in physiology, Faculty of Science / University of Kufa , Iraq.

19.   Jaeschke, H. (2006). Mechanisms of Liver Injury. II Mechanisms of neutrophil induced liver cell injury during hepatic ischemia reperfusion and other acute inflammatory conditions. Am. J. Physiol. Gastro. In test Liver Physiol., 290:G1083–G1088.

20.   Kim, W.R., Ludwig, J. and Lindor, K.D. (2000). Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol., 95:1130–1138.

21.   Padda, M.S., Singh, S., Tang, S.J. and Rockey, D.C.(2009). Liver test patterns in patients with acute calculouscholecystitis and/or choledocholithiasis. Aliment. Pharmacol. Ther., 29(9):1011–8.

22.   Olteanu, D., Filip, A., Mureşan, A., Nagy, A., Tabaran, F., Moldovan, R. and et al. (2012). The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats. Acta. Physiol. Hung., 99(1):61–73.

23.   Esmat, A. Y., Said, M.M., Soliman, A.A., ElMasry, K.S. and Badiea, E.A. (2013). Bioactive compounds, antioxidant potential, and hepatoprotective activity of sea cucumber (Holothuria atra) against thioacetamide intoxication in rats. Nutrition., 29(1):258–67.

24.   Tahan, C. (2010). Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. J Surg .,Vol. 53, No. 5.

25.   Naik, S.R. and Panda, V. S. (2008). Hepatoprotective effect of Ginkgo select Phytosome in rifampicin induced liver injury in rats: evidence of antioxidant activity. Fitoterapia., 79: 45-439.

26.   Noble, H., Whitley, E., Norton, S., Thompson, M. (2011). A study of preoperative factors associated with a poor outcome following laparoscopic bile duct exploration. Surg. Endosc.,25(1):130 9.

 

 

 

 

 

 

Received on 08.04.2017           Modified on 17.05.2017

Accepted on 23.05.2017          © RJPT All right reserved

Research J. Pharm. and Tech. 2017; 10(7): 2101-2105.

DOI: 10.5958/0974-360X.2017.00367.5